Below, a list of constituents for IBRN (iShares Neuroscience and Healthcare ETF) is shown. In total, IBRN consists of 86 securities.
Note: The data shown here is as of date Mar 31, 2026 (the latest that can be sourced directly from the fund provider).
Click here to go back to the full list of ETFs.
| Ticker | Name | Sector | Asset Class | Market Value | Weight (%) |
| XENE | XENON PHARMACEUTICALS INC | Health Care | Equity | 255020.49 | 4.79 |
| AXSM | AXSOME THERAPEUTICS INC | Health Care | Equity | 253842.28 | 4.77 |
| ALKS | ALKERMES | Health Care | Equity | 233667.5 | 4.39 |
| ARWR | ARROWHEAD PHARMACEUTICALS INC | Health Care | Equity | 231383.84 | 4.35 |
| CNTA | CENTESSA PHARMACEUTICALS AMERICAN | Health Care | Equity | 205728.62 | 3.87 |
| ARGX | ARGENX SE ADR | Health Care | Equity | 204237.9 | 3.84 |
| PRAX | PRAXIS PRECISION MEDICINES INC | Health Care | Equity | 197980.2 | 3.72 |
| NBIX | NEUROCRINE BIOSCIENCES INC | Health Care | Equity | 195566.88 | 3.68 |
| SRRK | SCHOLAR ROCK HOLDING CORP | Health Care | Equity | 192075.12 | 3.61 |
| PTCT | PTC THERAPEUTICS INC | Health Care | Equity | 191087.52 | 3.59 |
| BIIB | BIOGEN INC | Health Care | Equity | 189886.52 | 3.57 |
| CPRX | CATALYST PHARMACEUTICALS INC | Health Care | Equity | 186641.28 | 3.51 |
| ACAD | ACADIA PHARMACEUTICALS INC | Health Care | Equity | 186130.8 | 3.5 |
| DNTH | DIANTHUS THERAPEUTICS INC | Health Care | Equity | 180299.52 | 3.39 |
| EWTX | EDGEWISE THERAPEUTICS INC | Health Care | Equity | 160858.32 | 3.02 |
| DNLI | DENALI THERAPEUTICS INC | Health Care | Equity | 147576.0 | 2.77 |
| SUPN | SUPERNUS PHARMACEUTICALS INC | Health Care | Equity | 147570.0 | 2.77 |
| AXGN | AXOGEN INC | Health Care | Equity | 122472.0 | 2.3 |
| DYN | DYNE THERAPEUTICS INC | Health Care | Equity | 121696.02 | 2.29 |
| SRPT | SAREPTA THERAPEUTICS INC | Health Care | Equity | 119409.2 | 2.24 |
| 326030 | SK BIOPHARMACEUTICALS LTD | Health Care | Equity | 104883.15 | 1.97 |
| HLUN B | H. LUNDBECK CLASS B | Health Care | Equity | 98183.64 | 1.85 |
| CAPR | CAPRICOR THERAPEUTICS INC | Health Care | Equity | 88761.28 | 1.67 |
| TSHA | TAYSHA GENE THERAPIES INC | Health Care | Equity | 85840.86 | 1.61 |
| BIOA B | BIOARCTIC CLASS B | Health Care | Equity | 71379.07 | 1.34 |
| BHVN | BIOHAVEN LTD | Health Care | Equity | 68125.36 | 1.28 |
| RAPP | RAPPORT THERAPEUTICS INC | Health Care | Equity | 57299.9 | 1.08 |
| NEU | NEUREN PHARMACEUTICALS LTD | Health Care | Equity | 53841.29 | 1.01 |
| DYVOX | DYNAVOX GROUP | Information Technology | Equity | 49013.85 | 0.92 |
| IART | INTEGRA LIFESCIENCES HOLDINGS CORP | Health Care | Equity | 48583.5 | 0.91 |
| DRUG | BRIGHT MINDS BIOSCIENCES INC | Health Care | Equity | 46472.58 | 0.87 |
| IDIA | IDORSIA N LTD | Health Care | Equity | 45512.66 | 0.86 |
| ANNX | ANNEXON INC | Health Care | Equity | 40314.56 | 0.76 |
| ANRO | ALTO NEUROSCIENCE INC | Health Care | Equity | 39981.95 | 0.75 |
| 4592 | SANBIO LTD | Health Care | Equity | 39975.9 | 0.75 |
| LBRX | LB PHARMACEUTICALS INC | Health Care | Equity | 34063.68 | 0.64 |
| MEDCL | MEDINCELL SA | Health Care | Equity | 33907.79 | 0.64 |
| BWAY | BRAINSWAY ADR REPRESENTING LTD | Health Care | Equity | 30688.98 | 0.58 |
| CBLL | CERIBELL INC | Health Care | Equity | 27234.69 | 0.51 |
| PRTA | PROTHENA PLC | Health Care | Equity | 26766.48 | 0.5 |
| 2190 | ZYLOX-TONBRIDGE MEDICAL TECH LTD H | Health Care | Equity | 24948.0 | 0.47 |
| RLMD | RELMADA THERAPEUTICS INC | Health Care | Equity | 24504.9 | 0.46 |
| 4588 | ONCOLYS BIOPHARMA INC | Health Care | Equity | 24121.25 | 0.45 |
| NPCE | NEUROPACE INC | Health Care | Equity | 23821.92 | 0.45 |
| 2172 | MICROPORT NEUROTECH CORP | Health Care | Equity | 23429.42 | 0.44 |
| DSGN | DESIGN THERAPEUTICS INC | Health Care | Equity | 23387.04 | 0.44 |
| RGNX | REGENXBIO INC | Health Care | Equity | 23345.04 | 0.44 |
| SLDB | SOLID BIOSCIENCES INC | Health Care | Equity | 22783.8 | 0.43 |
| VNDA | VANDA PHARMACEUTICALS INC | Health Care | Equity | 22140.44 | 0.42 |
| BNTC | BENITEC BIOPHARMA INC | Health Care | Equity | 21935.6 | 0.41 |
| 9996 | PEIJIA MEDICAL LTD | Health Care | Equity | 20106.43 | 0.38 |
| NGNE | NEUROGENE INC | Health Care | Equity | 19621.32 | 0.37 |
| MPLT | MAPLIGHT THERAPEUTICS INC | Health Care | Equity | 18901.84 | 0.36 |
| TRDA | ENTRADA THERAPEUTICS INC | Health Care | Equity | 18553.5 | 0.35 |
| OVID | OVID THERAPEUTICS INC | Health Care | Equity | 18010.12 | 0.34 |
| NWRN | NEWRON PHARMACEUTICALS | Health Care | Equity | 16656.1 | 0.31 |
| AVXL | ANAVEX LIFE SCIENCES CORP | Health Care | Equity | 16608.48 | 0.31 |
| CLPT | CLEARPOINT NEURO INC | Health Care | Equity | 15739.8 | 0.3 |
| SANN | SANTHERA N AG | Health Care | Equity | 14012.79 | 0.26 |
| ALEC | ALECTOR INC | Health Care | Equity | 10557.56 | 0.2 |
| ACIU | AC IMMUNE SA | Health Care | Equity | 10083.5 | 0.19 |
| VYGR | VOYAGER THERAPEUTICS INC | Health Care | Equity | 9804.6 | 0.18 |
| IKT | INHIBIKASE THERAPEUTICS INC | Health Care | Equity | 9804.4 | 0.18 |
| TNXP | TONIX PHARMACEUTICALS HOLDING CORP | Health Care | Equity | 9288.0 | 0.17 |
| LRMR | LARIMAR THERAPEUTICS INC | Health Care | Equity | 9146.81 | 0.17 |
| 317450 | MYUNG IN PHARMA CO LTD | Health Care | Equity | 8067.46 | 0.15 |
| NMRA | NEUMORA THERAPEUTICS INC | Health Care | Equity | 7038.0 | 0.13 |
| PEPG | PEPGEN INC | Health Care | Equity | 6477.08 | 0.12 |
| ABOS | ACUMEN PHARMACEUTICALS INC | Health Care | Equity | 6438.6 | 0.12 |
| CGTX | COGNITION THERAPEUTICS INC | Health Care | Equity | 5385.32 | 0.1 |
| 6681 | BRAINAURORA MEDICAL TECHNOLOGY LTD | Health Care | Equity | 4887.51 | 0.09 |
| GANX | GAIN THERAPEUTICS INC | Health Care | Equity | 3829.76 | 0.07 |
| FLNA | FILANA THERAPEUTICS INC | Health Care | Equity | 3390.66 | 0.06 |
| XTSLA | BLK CSH FND TREASURY SL AGENCY | Cash and/or Derivatives | Money Market | 2441.79 | 0.05 |
| SGMO | SANGAMO THERAPEUTICS INC | Health Care | Equity | 2420.16 | 0.05 |
| HKD | HKD CASH | Cash and/or Derivatives | Cash | 1545.01 | 0.03 |
| AUD | AUD CASH | Cash and/or Derivatives | Cash | 1006.71 | 0.02 |
| JPY | JPY CASH | Cash and/or Derivatives | Cash | 876.35 | 0.02 |
| CHF | CHF CASH | Cash and/or Derivatives | Cash | 281.3 | 0.01 |
| SEK | SEK CASH | Cash and/or Derivatives | Cash | 190.76 | 0.0 |
| USD | USD CASH | Cash and/or Derivatives | Cash | 149.36 | 0.0 |
| KRW | KRW CASH | Cash and/or Derivatives | Cash | 130.63 | 0.0 |
| EUR | EUR CASH | Cash and/or Derivatives | Cash | 74.47 | 0.0 |
| DKK | DKK CASH | Cash and/or Derivatives | Cash | 69.68 | 0.0 |
| ETD_USD | ETD USD BALANCE WITH R30382 | Cash and/or Derivatives | Cash | -0.08 | 0.0 |
| The content contained herein is owned or licensed by BlackRock and/or its third-party information providers and is protected by applicable copyrights, trademarks, service marks, and/or other intellectual property rights. Such content is solely for your personal, non-commercial use. Accordingly, you may not copy, distribute, modify, post, frame or deep link this content. You may download material displayed on this Website for your personal use provided you also retain all copyright and other proprietary notices contained on the materials. Modification or use of the materials for any other purpose violates BlackRock's intellectual property rights. Holdings subject to change. See www.iShares.com for the most recent funds holdings. The values for “price” shown herein generally represent a price provided by a third-party pricing vendor for the portfolio holding and do not reflect the impact of systematic fair valuation (“the vendor price”). The vendor price is not necessarily the price at which the Fund values the portfolio holding for the purposes of determining its net asset value (the “valuation price”). Additionally, where applicable, foreign currency exchange rates with respect to the portfolio holdings denominated in non-U.S. currencies for the valuation price will be generally determined as of the close of business on the New York Stock Exchange, whereas for the vendor price will be generally determined as of 4 p.m. London. The values shown herein for “market value,” “weight,” and “notional value” (the “calculated values”) are based off of the vendor price and may have been different if the valuation price were to have been used to calculate such values. The vendor price is as of the most recent practicable date and may not necessarily be as of the date shown above. Please see the “Determination of Net Asset Value” section of each Fund’s prospectus for additional information on the Fund’s valuation policies and procedures. CAREFULLY CONSIDER THE FUNDS' INVESTMENT OBJECTIVES, RISK FACTORS, AND CHARGES AND EXPENSES BEFORE INVESTING. THIS AND OTHER INFORMATION CAN BE FOUND IN THE FUNDS' PROSPECTUSES OR, IF AVAILABLE, THE SUMMARY PROSPECTUSES WHICH MAY BE OBTAINED BY VISITING WWW.ISHARES.COM OR WWW.BLACKROCK.COM. READ THE PROSPECTUS CAREFULLY BEFORE INVESTING. INVESTING INVOLVES RISK, INCLUDING POSSIBLE LOSS OF PRINCIPAL. This information should not be relied upon as research, investment advice, or a recommendation regarding any products, strategies, or any security in particular. This material is strictly for illustrative, educational, or informational purposes and is subject to change. The Funds are distributed by BlackRock Investments, LLC (together with its affiliates, “BlackRock”). The iShares Funds are not sponsored, endorsed, issued, sold or promoted by Bloomberg, BlackRock Index Services, LLC, Cboe Global Indices, LLC, Cohen & Steers, European Public Real Estate Association (“EPRA® ”), FTSE International Limited (“FTSE”), ICE Data Indices, LLC, NSE Indices Ltd, JPMorgan, JPX Group, London Stock Exchange Group (“LSEG”), MSCI Inc., Markit Indices Limited, Morningstar, Inc., Nasdaq, Inc., National Association of Real Estate Investment Trusts (“NAREIT”), Nikkei, Inc., Russell, S&P Dow Jones Indices LLC or STOXX Ltd. None of these companies make any representation regarding the advisability of investing in the Funds. With the exception of BlackRock Index Services, LLC, who is an affiliate, BlackRock Investments, LLC is not affiliated with the companies listed above. Neither FTSE, LSEG, nor NAREIT makes any warranty regarding the FTSE Nareit Equity REITS Index, FTSE Nareit All Residential Capped Index or FTSE Nareit All Mortgage Capped Index. Neither FTSE, EPRA, LSEG, nor NAREIT makes any warranty regarding the FTSE EPRA Nareit Developed ex-U.S. Index, FTSE EPRA Nareit Developed Green Target Index or FTSE EPRA Nareit Global REITs Index. “FTSE®” is a trademark of London Stock Exchange Group companies and is used by FTSE under license. ©2023 BlackRock, Inc or its affiliates. All rights reserved. iSHARES, iBONDS and BLACKROCK are trademarks of BlackRock, Inc. or its affiliates. All other trademarks are those of their respective owners. | nan | nan | nan | nan | nan |
Alphalerts is a Chapati Systems GmbH Service.
Made with Chai in Germany.
